Request for Covid-19 Impact Assessment of this Report

Healthcare

United States Antiemetic Drugs Market Report 2017

  • QYR1329968
  • 95 Pages
  • July 2017
  • Healthcare
Download Sample    Get Discount   
 
In this report, the United States Antiemetic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Antiemetic Drugs in these regions, from 2012 to 2022 (forecast).

United States Antiemetic Drugs market competition by top manufacturers/players, with Antiemetic Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

GlaxoSmithKline

Pfizer

Johnson and Johnson

Astellas Pharma

Merck

Sanofi-Aventis

Baxter International

Abbott Labs

Cipla Ltd.

Novartis AG

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

Phenothiazine Drugs

Antihistamines

Anticholinergic Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antiemetic Drugs for each application, including

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Antiemetic Drugs Market Report 2017

1 Antiemetic Drugs Overview

1.1 Product Overview and Scope of Antiemetic Drugs

1.2 Classification of Antiemetic Drugs by Product Category

1.2.1 United States Antiemetic Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Antiemetic Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Phenothiazine Drugs

1.2.4 Antihistamines

1.2.5 Anticholinergic Drugs

1.3 United States Antiemetic Drugs Market by Application/End Users

1.3.1 United States Antiemetic Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 United States Antiemetic Drugs Market by Region

1.4.1 United States Antiemetic Drugs Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Antiemetic Drugs Status and Prospect (2012-2022)

1.4.3 Southwest Antiemetic Drugs Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Antiemetic Drugs Status and Prospect (2012-2022)

1.4.5 New England Antiemetic Drugs Status and Prospect (2012-2022)

1.4.6 The South Antiemetic Drugs Status and Prospect (2012-2022)

1.4.7 The Midwest Antiemetic Drugs Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Antiemetic Drugs (2012-2022)

1.5.1 United States Antiemetic Drugs Sales and Growth Rate (2012-2022)

1.5.2 United States Antiemetic Drugs Revenue and Growth Rate (2012-2022)

2 United States Antiemetic Drugs Market Competition by Players/Suppliers

2.1 United States Antiemetic Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Antiemetic Drugs Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Antiemetic Drugs Average Price by Players/Suppliers (2012-2017)

2.4 United States Antiemetic Drugs Market Competitive Situation and Trends

2.4.1 United States Antiemetic Drugs Market Concentration Rate

2.4.2 United States Antiemetic Drugs Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Antiemetic Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Antiemetic Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Antiemetic Drugs Sales and Market Share by Region (2012-2017)

3.2 United States Antiemetic Drugs Revenue and Market Share by Region (2012-2017)

3.3 United States Antiemetic Drugs Price by Region (2012-2017)

4 United States Antiemetic Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Antiemetic Drugs Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Antiemetic Drugs Revenue and Market Share by Type (2012-2017)

4.3 United States Antiemetic Drugs Price by Type (2012-2017)

4.4 United States Antiemetic Drugs Sales Growth Rate by Type (2012-2017)

5 United States Antiemetic Drugs Sales (Volume) by Application (2012-2017)

5.1 United States Antiemetic Drugs Sales and Market Share by Application (2012-2017)

5.2 United States Antiemetic Drugs Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Antiemetic Drugs Players/Suppliers Profiles and Sales Data

6.1 GlaxoSmithKline

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Antiemetic Drugs Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Pfizer

6.2.2 Antiemetic Drugs Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Pfizer Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Johnson and Johnson

6.3.2 Antiemetic Drugs Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Johnson and Johnson Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Astellas Pharma

6.4.2 Antiemetic Drugs Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Astellas Pharma Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Merck

6.5.2 Antiemetic Drugs Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Merck Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Sanofi-Aventis

6.6.2 Antiemetic Drugs Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Sanofi-Aventis Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Baxter International

6.7.2 Antiemetic Drugs Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Baxter International Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Abbott Labs

6.8.2 Antiemetic Drugs Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Abbott Labs Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Cipla Ltd.

6.9.2 Antiemetic Drugs Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Cipla Ltd. Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Novartis AG

6.10.2 Antiemetic Drugs Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Novartis AG Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

7 Antiemetic Drugs Manufacturing Cost Analysis

7.1 Antiemetic Drugs Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Antiemetic Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Antiemetic Drugs Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Antiemetic Drugs Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Antiemetic Drugs Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Antiemetic Drugs Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Antiemetic Drugs Sales Volume Forecast by Type (2017-2022)

11.3 United States Antiemetic Drugs Sales Volume Forecast by Application (2017-2022)

11.4 United States Antiemetic Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Antiemetic Drugs

Figure United States Antiemetic Drugs Market Size (K Pcs) by Type (2012-2022)

Figure United States Antiemetic Drugs Sales Volume Market Share by Type (Product Category) in 2016

Figure Phenothiazine Drugs Product Picture

Figure Antihistamines Product Picture

Figure Anticholinergic Drugs Product Picture

Figure United States Antiemetic Drugs Market Size (K Pcs) by Application (2012-2022)

Figure United States Sales Market Share of Antiemetic Drugs by Application in 2016

Figure Hospital Pharmacy Examples

Table Key Downstream Customer in Hospital Pharmacy

Figure Retail Pharmacy Examples

Table Key Downstream Customer in Retail Pharmacy

Figure Online Pharmacy Examples

Table Key Downstream Customer in Online Pharmacy

Figure United States Antiemetic Drugs Market Size (Million USD) by Region (2012-2022)

Figure The West Antiemetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Antiemetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Antiemetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Antiemetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Antiemetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Antiemetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Antiemetic Drugs Sales (K Pcs) and Growth Rate (2012-2022)

Figure United States Antiemetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Antiemetic Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table United States Antiemetic Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table United States Antiemetic Drugs Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Antiemetic Drugs Sales Share by Players/Suppliers

Figure 2017 United States Antiemetic Drugs Sales Share by Players/Suppliers

Figure United States Antiemetic Drugs Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Antiemetic Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Antiemetic Drugs Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Antiemetic Drugs Revenue Share by Players/Suppliers

Figure 2017 United States Antiemetic Drugs Revenue Share by Players/Suppliers

Table United States Market Antiemetic Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)

Figure United States Market Antiemetic Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016

Figure United States Antiemetic Drugs Market Share of Top 3 Players/Suppliers

Figure United States Antiemetic Drugs Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Antiemetic Drugs Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Antiemetic Drugs Product Category

Table United States Antiemetic Drugs Sales (K Pcs) by Region (2012-2017)

Table United States Antiemetic Drugs Sales Share by Region (2012-2017)

Figure United States Antiemetic Drugs Sales Share by Region (2012-2017)

Figure United States Antiemetic Drugs Sales Market Share by Region in 2016

Table United States Antiemetic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Antiemetic Drugs Revenue Share by Region (2012-2017)

Figure United States Antiemetic Drugs Revenue Market Share by Region (2012-2017)

Figure United States Antiemetic Drugs Revenue Market Share by Region in 2016

Table United States Antiemetic Drugs Price (USD/Pcs) by Region (2012-2017)

Table United States Antiemetic Drugs Sales (K Pcs) by Type (2012-2017)

Table United States Antiemetic Drugs Sales Share by Type (2012-2017)

Figure United States Antiemetic Drugs Sales Share by Type (2012-2017)

Figure United States Antiemetic Drugs Sales Market Share by Type in 2016

Table United States Antiemetic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Antiemetic Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Antiemetic Drugs by Type (2012-2017)

Figure Revenue Market Share of Antiemetic Drugs by Type in 2016

Table United States Antiemetic Drugs Price (USD/Pcs) by Types (2012-2017)

Figure United States Antiemetic Drugs Sales Growth Rate by Type (2012-2017)

Table United States Antiemetic Drugs Sales (K Pcs) by Application (2012-2017)

Table United States Antiemetic Drugs Sales Market Share by Application (2012-2017)

Figure United States Antiemetic Drugs Sales Market Share by Application (2012-2017)

Figure United States Antiemetic Drugs Sales Market Share by Application in 2016

Table United States Antiemetic Drugs Sales Growth Rate by Application (2012-2017)

Figure United States Antiemetic Drugs Sales Growth Rate by Application (2012-2017)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure GlaxoSmithKline Antiemetic Drugs Sales Growth Rate (2012-2017)

Figure GlaxoSmithKline Antiemetic Drugs Sales Market Share in United States (2012-2017)

Figure GlaxoSmithKline Antiemetic Drugs Revenue Market Share in United States (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Pfizer Antiemetic Drugs Sales Growth Rate (2012-2017)

Figure Pfizer Antiemetic Drugs Sales Market Share in United States (2012-2017)

Figure Pfizer Antiemetic Drugs Revenue Market Share in United States (2012-2017)

Table Johnson and Johnson Basic Information List

Table Johnson and Johnson Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Johnson and Johnson Antiemetic Drugs Sales Growth Rate (2012-2017)

Figure Johnson and Johnson Antiemetic Drugs Sales Market Share in United States (2012-2017)

Figure Johnson and Johnson Antiemetic Drugs Revenue Market Share in United States (2012-2017)

Table Astellas Pharma Basic Information List

Table Astellas Pharma Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Astellas Pharma Antiemetic Drugs Sales Growth Rate (2012-2017)

Figure Astellas Pharma Antiemetic Drugs Sales Market Share in United States (2012-2017)

Figure Astellas Pharma Antiemetic Drugs Revenue Market Share in United States (2012-2017)

Table Merck Basic Information List

Table Merck Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Merck Antiemetic Drugs Sales Growth Rate (2012-2017)

Figure Merck Antiemetic Drugs Sales Market Share in United States (2012-2017)

Figure Merck Antiemetic Drugs Revenue Market Share in United States (2012-2017)

Table Sanofi-Aventis Basic Information List

Table Sanofi-Aventis Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Sanofi-Aventis Antiemetic Drugs Sales Growth Rate (2012-2017)

Figure Sanofi-Aventis Antiemetic Drugs Sales Market Share in United States (2012-2017)

Figure Sanofi-Aventis Antiemetic Drugs Revenue Market Share in United States (2012-2017)

Table Baxter International Basic Information List

Table Baxter International Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Baxter International Antiemetic Drugs Sales Growth Rate (2012-2017)

Figure Baxter International Antiemetic Drugs Sales Market Share in United States (2012-2017)

Figure Baxter International Antiemetic Drugs Revenue Market Share in United States (2012-2017)

Table Abbott Labs Basic Information List

Table Abbott Labs Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Abbott Labs Antiemetic Drugs Sales Growth Rate (2012-2017)

Figure Abbott Labs Antiemetic Drugs Sales Market Share in United States (2012-2017)

Figure Abbott Labs Antiemetic Drugs Revenue Market Share in United States (2012-2017)

Table Cipla Ltd. Basic Information List

Table Cipla Ltd. Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Cipla Ltd. Antiemetic Drugs Sales Growth Rate (2012-2017)

Figure Cipla Ltd. Antiemetic Drugs Sales Market Share in United States (2012-2017)

Figure Cipla Ltd. Antiemetic Drugs Revenue Market Share in United States (2012-2017)

Table Novartis AG Basic Information List

Table Novartis AG Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Novartis AG Antiemetic Drugs Sales Growth Rate (2012-2017)

Figure Novartis AG Antiemetic Drugs Sales Market Share in United States (2012-2017)

Figure Novartis AG Antiemetic Drugs Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Antiemetic Drugs

Figure Manufacturing Process Analysis of Antiemetic Drugs

Figure Antiemetic Drugs Industrial Chain Analysis

Table Raw Materials Sources of Antiemetic Drugs Major Players/Suppliers in 2016

Table Major Buyers of Antiemetic Drugs

Table Distributors/Traders List

Figure United States Antiemetic Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Antiemetic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Antiemetic Drugs Price (USD/Pcs) Trend Forecast (2017-2022)

Table United States Antiemetic Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Antiemetic Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Antiemetic Drugs Sales Volume (K Pcs) Forecast by Type in 2022

Table United States Antiemetic Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Antiemetic Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Antiemetic Drugs Sales Volume (K Pcs) Forecast by Application in 2022

Table United States Antiemetic Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)

Table United States Antiemetic Drugs Sales Volume Share Forecast by Region (2017-2022)

Figure United States Antiemetic Drugs Sales Volume Share Forecast by Region (2017-2022)

Figure United States Antiemetic Drugs Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370